In the same study [30], the authors tested the effect of a 4-week treatment with the Hh signaling inhibitor GDC-0449 (SMO inhibitor) on 8-month-old Men1-mutated mice with insulinomas, showing a reduction of proliferation of beta cells of approximately 60% and a reduction of circulating levels of insulin. Here, INS is linked to pancreatic insulinoma.